INS and COVID-19: Both patients with acute COVID-19 and those recovering from COVID-19 were found to have an increased insulin response to arginine stimulation compared with healthy individuals, which suggested that COVID-19 may cause β-cell hypersecretion, which could, in turn, result in relative secretory failure [12].